Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • True North sells Aster...

    True North sells Aster DM Healthcare stake worth Rs 448 crore

    Farhat NasimWritten by Farhat Nasim Published On 2019-06-30T09:18:13+05:30  |  Updated On 30 Jun 2019 9:18 AM IST
    True North sells Aster DM Healthcare stake worth Rs 448 crore

    According to the shareholding pattern available on BSE NSE 0.03 %, at the end of March quarter, True North III A, held 8.23 per cent stake in Aster DM Healthcare, which runs hospitals in India and the Middle East.


    New Delhi: Private equity firm True North has sold 7.39 per cent stake in Aster DM HealthcareNSE -0.43 % worth over Rs 448 crore through open market transactions. A total of 3.73 crore shares, amounting to 7.39 per cent stake, were offloaded by True North Fund IIIA at a price of Rs 120.03 per scrip Wednesday, translating into Rs 448.47-crore transaction, according to bulk deal data available on NSE.


    According to the shareholding pattern available on BSE NSE 0.03 %, at the end of March quarter, True North III A, held 8.23 per cent stake in Aster DM Healthcare, which runs hospitals in India and the Middle East.

    Also Read: Aster DM Healthcare Q4 net profit up 7.1 per cent to Rs 219.84 crore


    In separate transactions, HDFC Mutual Fund bought 83 lakh shares of Aster DM for Rs 99.6 crore, Tata AIA Insurance purchased 50 lakh shares worth Rs 60 crore, while Fidelity Management and Ontario Pension Board bought 48.28 lakh shares and 27.6 lakh scrips, respectively for Rs 57.94 crore and Rs 33.18 crore.


    The four entities bought the shares at Rs 120 apiece.


    Also Read: Aster DM Healthcare to infuse Rs 750 crore to add 1500 beds in four new hospitals

    AIA InsuranceAsterAster DMAster DM HealthcareAzad Moopenbest insurance policyBSEFidelity ManagementHDFCHealthcareinsuranceNSEOntario Pension BoardTrue NorthUAE
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok